From the notice

(i)This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00025. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a firm-fixed-price purchase order without providing for full and open competition (brand-name only). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Lonza Walkersville, Inc., 8830 Biggs Ford Road, Walkersville, MD 21793, for the 4D-Nucleofector Core Unit and X Unit, including one-year warranty extensions. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.

Read the whole notice and its files on SAM.gov ↗